Vor Biopharma, Inc. (VOR)
18.03
-1.31
(-6.77%)
USD |
NASDAQ |
Oct 16, 16:00
17.73
-0.30
(-1.66%)
After-Hours: 20:00
Vor Biopharma Net Income (Quarterly) : -62.81M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -62.81M |
| March 31, 2026 | -219.58M |
| December 31, 2025 | 1.723B |
| September 30, 2025 | -812.68M |
| June 30, 2025 | -1.574B |
| March 31, 2025 | -32.49M |
| December 31, 2024 | -30.71M |
| September 30, 2024 | -27.56M |
| June 30, 2024 | -27.84M |
| March 31, 2024 | -30.80M |
| December 31, 2023 | -26.26M |
| September 30, 2023 | -33.19M |
| June 30, 2023 | -29.98M |
| March 31, 2023 | -28.43M |
| Date | Value |
|---|---|
| December 31, 2022 | -23.91M |
| September 30, 2022 | -23.79M |
| June 30, 2022 | -21.66M |
| March 31, 2022 | -22.74M |
| December 31, 2021 | -18.25M |
| September 30, 2021 | -18.55M |
| June 30, 2021 | -18.37M |
| March 31, 2021 | -13.72M |
| December 31, 2020 | -15.66M |
| September 30, 2020 | -11.78M |
| June 30, 2020 | -8.04M |
| March 31, 2020 | -7.849M |
| December 31, 2019 | -3.893M |
| September 30, 2019 | -3.639M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 2.375B |
| Anika Therapeutics, Inc. | 3.309M |
| BioCryst Pharmaceuticals, Inc. | 78.40M |
| Imunon, Inc. | -2.814M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 62.81M |
| EPS Diluted (Quarterly) | -1.157 |
| Enterprise Value | 518.59M |
| Earnings Yield | -462.5% |
| Normalized Earnings Yield | -160.93 |